(Q39293213)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Elisabeth Polard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Olivia Guillard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Emmanuelle Leray

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Hervé Allain

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Loïc Javaudin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Gilles Edan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

8 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

937-946

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

Origin of fatigue in multiple sclerosis: review of the literature

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5442-6

3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5442-6

4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5442-6

A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5442-6

Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5442-6

Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis

21 January 2018

1 reference

12 December 2020

[Comparison of acute toxicity of some aminopyridines in vivo (mice) and in vitro (tissue culture)]

1 reference

12 December 2020

Practical aspects of 3,4-diaminopyridine treatment of the Lambert-Eaton myasthenic syndrome

1 reference

12 December 2020

The current status of studies of aminopyridines in patients with multiple sclerosis

1 reference

12 December 2020

3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS).

1 reference

12 December 2020

[The treatment of the Eaton-Lambert myasthenic syndrome with 3,4-diaminopyridine]

1 reference

12 December 2020

Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome

1 reference

12 December 2020

A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit

1 reference

12 December 2020

The acute oral toxicity, repellency, and hazard potential of 998 chemicals to one or more species of wild and domestic birds

1 reference

12 December 2020

SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF SOME AMINOPYRIDINES, IMIDAZOPYRIDINES, AND TRIAZOLOPYRIDINES

1 reference

12 December 2020

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

1 reference

12 December 2020

No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study.

1 reference

12 December 2020

PHARMACOLOGY OF 3, 4-DIAMINOPYRIDINE

1 reference

12 December 2020

1 reference

12 December 2020

EDMUS, a European database for multiple sclerosis

1 reference

12 December 2020

3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia

1 reference

12 December 2020

Harmonisation in pharmacovigilance

1 reference

12 December 2020

Epileptic and non-epileptic seizures in multiple sclerosis

1 reference

12 December 2020

Fetal exposure to 3,4-diaminopyridine in a pregnant woman with congenital myasthenia syndrome

1 reference

12 December 2020

3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis

1 reference

12 December 2020

Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment

1 reference

12 December 2020

Lambert-Eaton myasthenic syndrome with ophthalmoparesis and pseudoblepharospasm

1 reference

12 December 2020

An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis

1 reference

12 December 2020

Aminopyridines for symptomatic treatment in multiple sclerosis

1 reference

12 December 2020

[Long-term treatment of Lambert-Eaton syndrome by 3, 4 diaminopyridine]

1 reference

12 December 2020

Establishment and use of multiple sclerosis registers--EDMUS.

1 reference

12 December 2020

10.1007/S00415-009-5442-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20058019%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference